BACKGROUND: Prior studies have reported conflicting findings concerning the association of socioeconomic status (SES), treatment, and outcomes in patients hospitalized with heart failure (HF). METHODS: We conducted a retrospective analysis of medical record data from a national sample of Medicare beneficiaries hospitalized with HF between March 1998 and April 1999 (n = 25,086) to assess the association of patient SES, treatment, and outcomes. Patients' SES was designated as lower, lower-middle, higher-middle, and higher using residential ZIP code characteristics. Patients were evaluated for left ventricular systolic function assessment, prescription of angiotensin-converting enzyme inhibitors at discharge, readmission within 1 year of discharge, and mortality within 30 days and 1 year of admission. Hierarchical logistic regression models were used to assess the association of SES, quality of care, and outcomes adjusting for patient, physician, and hospital characteristics. RESULTS: Lower SES patients (relative risk [RR] 0.92, 95% CI 0.87-0.96) were modestly less likely to have had a left ventricular systolic function assessment, but had a similar adjusted likelihood of being prescribed angiotensin-converting enzyme inhibitors (RR 1.03, 95% CI 0.93-1.11) compared with higher SES patients after multivariable adjustment. Socioeconomic status was not associated with 30-day mortality after multivariable adjustment, but lower SES patients had a higher risk of 1-year mortality (RR 1.10, 95% CI 1.02-1.19) and readmission within 1 year of discharge (RR 1.08, 95% CI 1.03-1.12) compared with higher SES patients. CONCLUSIONS: Socioeconomic status in patients hospitalized with HF was not strongly associated with quality of care or 30-day mortality. However, the increased risk of 1-year mortality and readmission among patients of lower SES suggest SES may influence outcomes after hospitalization for HF.
BACKGROUND: Prior studies have reported conflicting findings concerning the association of socioeconomic status (SES), treatment, and outcomes in patients hospitalized with heart failure (HF). METHODS: We conducted a retrospective analysis of medical record data from a national sample of Medicare beneficiaries hospitalized with HF between March 1998 and April 1999 (n = 25,086) to assess the association of patient SES, treatment, and outcomes. Patients' SES was designated as lower, lower-middle, higher-middle, and higher using residential ZIP code characteristics. Patients were evaluated for left ventricular systolic function assessment, prescription of angiotensin-converting enzyme inhibitors at discharge, readmission within 1 year of discharge, and mortality within 30 days and 1 year of admission. Hierarchical logistic regression models were used to assess the association of SES, quality of care, and outcomes adjusting for patient, physician, and hospital characteristics. RESULTS: Lower SES patients (relative risk [RR] 0.92, 95% CI 0.87-0.96) were modestly less likely to have had a left ventricular systolic function assessment, but had a similar adjusted likelihood of being prescribed angiotensin-converting enzyme inhibitors (RR 1.03, 95% CI 0.93-1.11) compared with higher SES patients after multivariable adjustment. Socioeconomic status was not associated with 30-day mortality after multivariable adjustment, but lower SES patients had a higher risk of 1-year mortality (RR 1.10, 95% CI 1.02-1.19) and readmission within 1 year of discharge (RR 1.08, 95% CI 1.03-1.12) compared with higher SES patients. CONCLUSIONS: Socioeconomic status in patients hospitalized with HF was not strongly associated with quality of care or 30-day mortality. However, the increased risk of 1-year mortality and readmission among patients of lower SES suggest SES may influence outcomes after hospitalization for HF.
Authors: H M Krumholz; D W Baker; C M Ashton; S B Dunbar; G C Friesinger; E P Havranek; M A Hlatky; M Konstam; D L Ordin; I L Pina; B Pitt; J A Spertus Journal: Circulation Date: 2000-03-28 Impact factor: 29.690
Authors: S S Rathore; A K Berger; K P Weinfurt; M Feinleib; W J Oetgen; B J Gersh; K A Schulman Journal: Circulation Date: 2000-08-08 Impact factor: 29.690
Authors: K MacIntyre; S Capewell; S Stewart; J W Chalmers; J Boyd; A Finlayson; A Redpath; J P Pell; J J McMurray Journal: Circulation Date: 2000-09-05 Impact factor: 29.690
Authors: M R Cowie; K F Fox; D A Wood; C Metcalfe; S G Thompson; A J S Coats; P A Poole-Wilson; G C Sutton Journal: Eur Heart J Date: 2002-06 Impact factor: 29.983
Authors: Rashmee U Shah; Marilyn A Winkleby; Linda Van Horn; Lawrence S Phillips; Charles B Eaton; Lisa W Martin; Milagros C Rosal; Joann E Manson; Hongyan Ning; Donald M Lloyd-Jones; Liviu Klein Journal: J Am Coll Cardiol Date: 2011-09-27 Impact factor: 24.094
Authors: John R Kapoor; Roger Kapoor; Anne S Hellkamp; Adrian F Hernandez; Paul A Heidenreich; Gregg C Fonarow Journal: J Am Coll Cardiol Date: 2011-09-27 Impact factor: 24.094
Authors: Khadijah Breathett; Rachel D'Amico; T M Ayodele Adesanya; Stefanie Hatfield; Shannon Willis; Rodney X Sturdivant; Randi E Foraker; Sakima Smith; Philip Binkley; William T Abraham; Pamela N Peterson Journal: Circ Heart Fail Date: 2017-06 Impact factor: 8.790
Authors: Linda Calvillo-King; Danielle Arnold; Kathryn J Eubank; Matthew Lo; Pete Yunyongying; Heather Stieglitz; Ethan A Halm Journal: J Gen Intern Med Date: 2012-10-06 Impact factor: 5.128
Authors: Jeph Herrin; Justin St Andre; Kevin Kenward; Maulik S Joshi; Anne-Marie J Audet; Stephen C Hines Journal: Health Serv Res Date: 2014-04-09 Impact factor: 3.402
Authors: M M S G Cardena; A K Ribeiro-Dos-Santos; S E B Santos; A J Mansur; S Bernardez-Pereira; P C J L Santos; A C Pereira; C Fridman Journal: J Hum Hypertens Date: 2015-05-07 Impact factor: 3.012